LY4065967
DrugAdministered orally.
NCT Number: NCT07641504
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 2
Ponce Medical School Foundation Inc., Ponce, Puerto Rico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administered orally.
Administered orally
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Time frame: Week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Contact information is provided by the study sponsor or research team.
Physicians interested in becoming principal investigators please contact
CONTACT
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
Eli Lilly and Company
Industry
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Chronic Low Back Pain
Acronym: BP07
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07190807
Back Pain, Chronic Leg Pain
Greenwood, Colorado, United States
View Trial DetailsNCT06454669
Back Injuries, Back Pain
Houston, Texas, United States
View Trial DetailsNCT06671132
Back Pain, Chronic Pain
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05752396
Back Pain, Brain Diseases
Cincinnati, Ohio, United States
View Trial Details